Musgrove Delivers New Radiotherapy Treatment With Less Side Effects For Patients

Musgrove Park Hospital's Radiotherapy Department has recently treated their first patient using a new method of treatment known as Intensity Modulated Radiotherapy (IMRT).

Intensity Modulated Radiotherapy is a new method of delivering treatment to patients undergoing radiotherapy. It bends the beam of radiation so there is less damage to normal tissues, which means patients experience fewer side effects than with traditional radiotherapy.

Patients needing head and neck radiotherapy are undergoing the treatment first, before it is implemented across a wider range of cancers over the forthcoming year.

The new treatment has been made possible thanks to donations from the Somerset Unit for Radiotherapy Equipment (SURE) and Musgrove Leukemic Group Somerset (MLGS).

Andrew Morgan, head of radiotherapy physics at Musgrove Park Hospital said, “The implementation of IMRT represents a significant advance in the on-going development of the service we provide.

Musgrove Delivers New Radiotherapy Treatment With Less Side Effects For Patients
“By using IMRT treatment, patients experience fewer side effects and by starting this treatment we can now enter clinical trials which look into the possibility of using fewer radiotherapy treatments to give the same effect.

"In September 2013, we will be implementing Volumetric Modulated Arc Therapy (VMAT), the next step on from IMRT, which speeds up the delivery of each treatment.

"We are extremely grateful to Somerset Unit for Radiotherapy (SURE) and Musgrove Leukemic Group Somerset (MLGS) for their continued support."

Somerset Unit for Radiotherapy Equipment (SURE) purchased specialised computer systems and software to allow treatments such as IMRT to be accurately planned and Musgrove Leukemic Group Somerset (MLGS) purchased equipment to allow these complex treatments to be checked prior to delivery.

Images: Pictured from left to right are: Vasu Ganesan, Clinical Scientist,Kelly Mundy, Radiographer Steve McCormack, Clinical Scientist Andrew Morgan, Clinical Scientist Simon Goldsworthy, Radiographer Mandy Pitt, Dosimetrist.

Categories: